Sana Biotechnology (SANA) Other Accumulated Expenses (2020 - 2026)

Sana Biotechnology has disclosed Other Accumulated Expenses across 7 years of filings, most recently posting $1.8 million for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $1.8 million, up 16.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (up 16.02% YoY), and the FY2025 annual result was $1.6 million, down 9.06% from the prior year.
• Other Accumulated Expenses came in at $1.8 million for Q1 2026 at Sana Biotechnology, up from $1.6 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $3.7 million in Q3 2024 to a low of $1.3 million in Q3 2025.
• The 5-year median for Other Accumulated Expenses is $2.1 million (2023), against an average of $2.3 million.
• Across the five-year window, Other Accumulated Expenses soared 9266.67% in 2022 and plunged 64.08% in 2025, its largest moves.
• Sana Biotechnology's Other Accumulated Expenses stood at $2.9 million in 2022, then fell by 6.42% to $2.7 million in 2023, then plunged by 34.6% to $1.8 million in 2024, then declined by 9.06% to $1.6 million in 2025, then climbed by 11.72% to $1.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $1.8 million (Q1 2026), $1.6 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.